Western blot results demonstrated that IFI35 expression was significantly reduced in IFI35 shRNA-treated Ketr-3 or 786-O cells, indicating that IFI35 expression was effectively suppressed by shRNA in renal cancer cells (Figure 2B). This evidence concerns the gene IFI35 and renal carcinoma.